|
C14ORF167 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70190544884963E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21189971788749E-10 |
| Normal-vs-Stage2 |
2.555800E-03 |
| Normal-vs-Stage3 |
1.197910E-03 |
| Normal-vs-Stage4 |
1.02310000471562E-08 |
| Stage1-vs-Stage2 |
8.983200E-01 |
| Stage1-vs-Stage3 |
1.854210E-01 |
| Stage1-vs-Stage4 |
1.031500E-02 |
| Stage2-vs-Stage3 |
5.781200E-01 |
| Stage2-vs-Stage4 |
2.396000E-01 |
| Stage3-vs-Stage4 |
8.522100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35319999650108E-09 |
| Normal-vs-AfricanAmerican |
4.97110019814784E-10 |
| Normal-vs-Asian |
2.182300E-02 |
| Caucasian-vs-AfricanAmerican |
3.014500E-02 |
| Caucasian-vs-Asian |
9.548800E-01 |
| AfricanAmerican-vs-Asian |
4.692000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41659999958388E-07 |
| Normal-vs-Female |
1.951810E-04 |
| Male-vs-Female |
1.498430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.553200E-04 |
| Normal-vs-Extreme_Weight |
1.41799999964221E-07 |
| Normal-vs-Obese |
3.78919999821647E-08 |
| Normal-vs-Extreme_Obese |
6.486400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.101000E-01 |
| Normal_Weight-vs-Obese |
5.730600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.664200E-01 |
| Extreme_Weight-vs-Obese |
5.026600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.929230E-01 |
| Obese-vs-Extreme_Obese |
1.423560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.77180000000244E-05 |
| Normal-vs-Age(41-60Yrs) |
8.70629999982775E-07 |
| Normal-vs-Age(61-80Yrs) |
1.10000000219657E-08 |
| Normal-vs-Age(81-100Yrs) |
5.538900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.529800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.341600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.782000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.587000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.180600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.838600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.97929999945501E-07 |
| Normal-VS-Type2 PRCC |
5.008100E-04 |
| Normal-VS-KIRP CIMP |
3.50789997050072E-09 |
| Normal-VS-Unclassified PRCC |
1.65779999999893E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.920100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.017500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.803000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.840750E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.858000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.314030E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70920000042152E-07 |
| Normal-vs-N1 |
3.434600E-04 |
| Normal-vs-N2 |
1.964940E-03 |
| N0-vs-N1 |
5.601800E-01 |
| N0-vs-N2 |
1.316640E-01 |
| N1-vs-N2 |
1.204780E-01 |
|
|
